BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2026.
World J Gastrointest Endosc. Feb 16, 2026; 18(2): 116518
Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.116518
Table 3 Multivariate analysis of the predictors of > 50% reduction in total bilirubin by day 7 and total bilirubin < 3 mg/dL by day 15
Variables> 50% in bilirubin by day 7
Bilirubin < 3 mg/dL by day 15
Odds ratio (95%CI)
P value
Odds ratio (95%CI)
P value
Age0.952 (0.910-0.995)0.030.989 (0.939-1.043)0.689
Female gender0.723 (0.236-2.215)0.5710.622 (0.145-2.664)0.522
No cholangitis at baseline0.639 (0.210-2.029)0.4474.944 (0.857-28.524)0.074
Benign etiology4.303 (1.085-17.059)0.0381.226 (0.239-6.303)0.807
Baseline total bilirubin0.935 (0.849-1.030)0.1750.79 (0.72-0.89)< 0.001
ALP1.002 (1.000-1.004)0.0661.002 (1.000-1.003)0.043


Write to the Help Desk